A case of heparin-induced thrombocytopenia (HIT) triggered by methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia

被引:0
|
作者
Sugioka S. [1 ]
Doi Y. [1 ]
Ishihara T. [2 ]
Arisato T. [1 ]
Osaki K. [1 ]
Koga K. [1 ]
Koshikawa M. [1 ]
Sugawara A. [1 ]
机构
[1] Department of Nephrology, Osaka Red Cross Hospital, Osaka
[2] Department of Clinical Engineering, Osaka Red Cross Hospital, Osaka
关键词
Antigen assay; Functional assay; HIT; Hypercoagulable state; MSSA bacteremia;
D O I
10.1186/s41100-016-0073-8
中图分类号
学科分类号
摘要
Background: Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening complication of heparin anticoagulation. Recently, infection has been implicated in the development of HIT. Case presentation: We herein present a case of HIT diagnosed by a repeated functional assay. A 67-year-old female with diabetic nephropathy was admitted to our hospital with hypoxemia caused by volume overload. Due to her diuretic-resistant condition, dialysis therapy anticoagulated with low-molecular-weight heparin (LMWH) was initiated. The coagulation of the whole extracorporeal blood circuit occurred on day 13. Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia derived from a catheter-related bloodstream infection (CRBSI) was detected on day 15. Based on the hypercoagulable state due to infection, we increased the heparin dose during dialysis therapy; however, coagulation of the dialysis circuit persisted. We suspected HIT on day 17 in spite of a normal platelet count and performed a functional assay, which was negative. Since thrombocytopenia subsequently developed, the functional assay was repeated and a positive result was obtained on day 27, which definitely established a diagnosis of HIT. Conclusions: Based on the present clinical course, MSSA bacteremia appears to have contributed to the pathogenesis of HIT. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] A CASE OF HIT (HEPARIN-INDUCED THROMBOCYTOPENIA) TRIGGERED BY MSSA BACTEREMIA
    Sugioka, S.
    Doi, Y.
    Ishihara, T.
    Inoue, Y.
    Arisato, T.
    Osaki, K.
    Koga, K.
    Nishioka, K.
    Koshikawa, M.
    Sugawara, A.
    NEPHROLOGY, 2016, 21 : 252 - 253
  • [2] Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Stefano Di Bella
    Milo Gatti
    Luigi Principe
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 917 - 918
  • [3] Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Di Bella, Stefano
    Gatti, Milo
    Principe, Luigi
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (07) : 917 - 918
  • [4] DEVASTATING METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA WITH AN UNKNOWN SOURCE
    Kagita, Navyamani V.
    Thota, Vihitha
    Jain, Akhil
    Ikoro, Udunma N.
    Sheu, Wei-Chun
    Russell, Steven
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S324 - S324
  • [5] Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan
    Shoji, Takayo
    Hirai, Yuji
    Osawa, Makiko
    Totsuka, Kyoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 175 - 180
  • [6] Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
    Davie Wong
    Titus Wong
    Marc Romney
    Victor Leung
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [7] Vancomycin-Induced Neutropenia in Status Asthmaticus with Methicillin-Susceptible Staphylococcus Aureus Bacteremia
    Jensen, M.
    Liberg, R.
    Harner, W. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Maria Aguado, Jose
    San-Juan, Rafael
    Lalueza, Antonio
    Sanz, Francisca
    Rodriguez-Otero, Joaquin
    Gomez-Gonzalez, Carmen
    Chaves, Fernando
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1099 - 1102
  • [9] Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
    Monogue, Marguerite L.
    Ortwine, Jessica K.
    Wei, Wenjing
    Eljaaly, Khalid
    Bhavan, Kavita P.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 727 - 731
  • [10] Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
    Lee, Shinwon
    Choe, Pyoeng Gyun
    Song, Kyoung-Ho
    Park, Sang-Won
    Kim, Hong Bin
    Kim, Nam Joong
    Kim, Eui-Chong
    Park, Wan Beom
    Oh, Myoung-don
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5122 - 5126